Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes total assets
Total assets on the balance sheet at the end of each period.
Alkermes's total assets was $4.39B at Jun 30, 2026. For fiscal 2025 it was $2.49B, up 21.0% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $2.49B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.49B | +21.0% |
| FY2024 | Dec 31, 2024 | $2.06B | -3.8% |
| FY2023 | Dec 31, 2023 | $2.14B | +8.8% |
| FY2022 | Dec 31, 2022 | $1.96B | -3.0% |
| FY2021 | Dec 31, 2021 | $2.02B | +3.8% |
| FY2020 | Dec 31, 2020 | $1.95B | +8.0% |
| FY2019 | Dec 31, 2019 | $1.81B | -1.1% |
| FY2018 | Dec 31, 2018 | $1.83B | +1.5% |
| FY2017 | Dec 31, 2017 | $1.80B | +4.1% |
| FY2016 | Dec 31, 2016 | $1.73B | -7.0% |
| FY2015 | Dec 31, 2015 | $1.86B | +26.2% |
| FY2013 | Mar 31, 2013 | $1.47B | +2.4% |
| FY2012 | Mar 31, 2012 | $1.44B | +217.2% |
| FY2011 | Mar 31, 2011 | $452.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.39B | +95.0% |
| Q1 FY2026 | Mar 31, 2026 | $4.26B | +104.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.49B | +21.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.33B | +8.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.25B | +2.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.08B | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.06B | -3.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.16B | -5.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.21B | +0.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.12B | +10.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.14B | +8.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.28B | +17.4% |
| Q2 FY2023 | Jun 30, 2023 | $2.19B | +11.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.92B | -2.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.96B | -3.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.94B | -2.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.96B | +1.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.98B | +5.3% |
| Q4 FY2021 | Dec 31, 2021 | $2.02B | +3.8% |
| Q3 FY2021 | Sep 30, 2021 | $2.00B | +6.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.94B | +7.5% |
| Q1 FY2021 | Mar 31, 2021 | $1.88B | +2.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.95B | +8.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.88B | +6.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.80B | +2.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.83B | +4.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.81B | -1.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.76B | -0.2% |
| Q2 FY2019 | Jun 30, 2019 | $1.75B | +0.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.76B | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.83B | +1.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.76B | +0.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.75B | +1.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.74B | +0.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.80B | +4.1% |
| Q3 FY2017 | Sep 30, 2017 | $1.75B | +2.4% |
| Q2 FY2017 | Jun 30, 2017 | $1.73B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.73B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.73B | – |
| Q3 FY2016 | Sep 30, 2016 | $1.71B | – |
See a number that looks wrong?